high purity API Pim...

high purity API Pimecrolimus 137071-32-0 exporter

high purity API Pimecrolimus 137071-32-0 exporter

Min.Order / FOB Price:Get Latest Price

1 Kilogram

Negotiable

  • Min.Order :1 Kilogram
  • Purity: refer to COA
  • Payment Terms : L/C,T/T

Keywords

API Pimecrolimus 137071-32-0 137071-32-0 exporter high purity Pimecrolimus

Quick Details

  • Appearance:refer to COA
  • Application:Immunosuppressant
  • PackAge:25kg/drum or client's request
  • ProductionCapacity:15|Metric Ton|Month
  • Storage:Store in a well-closed place with room temperature and no direct sun light.
  • Transportation:By sea; By air;by courier

Superiority:

high purity API Pimecrolimus 137071-32-0 exporter

Enbridge PharmTech Co., Ltd. is an innovative company integrated with R&D, manufacturing, marketing and distribution of intermediates and fine chemicals, mainly used to pharmaceutical, pesticide, cosmetics, health care products and electronic chemicals. Our core services also include Custom Synthesis and Contract Manufacturing Services.
Enbridge PharmTech has one R&D center and two manufacturing bases. R&D center is equipped with good organic synthesis and analytical instrumenets. In our two production bases, we have large-scale reactors which cover various SS/ Glass Lined reactors capable of conducting high pressure, high temperature and low temperature reactions. We have a large number of well-equiped instruments and have the production capability from kilogram to ton...

Molecular Formula:C43H68ClNO11 
Molecular Weight:810.4531 
CAS :137071-32-0 
Density:1.19g/cm3

Boiling point:866.1°C at 760 mmHg
Refractive index:1.543
Flash point:477.6°C
Vapour Pressur:5.44E-35mmHg at 25°C
Chemical Name Pimecrolimus
Synonyms


33-epi-33-chloro-FR 520;SDZ-ASM 981;Elidel;33-epi-chloro-33-desoxy-ascomycin;Expand

CAS No. 137071-32-0
Molecular Formula C43H68ClNO11
Molecular Weight 810.45300
PSA 158.13000
LogP 5.65730

Properties

Appearance & Physical State white crystalline powder
Density 1.19
Boiling Point 866.1ºC at 760 mmHg
Flash Point 477.6ºC
Refractive Index 1.543
Vapor Pressure 5.44E-35mmHg at 25°C

 Function
 
Pimecrolimus is a semi-synthetic, macrocyclic lactone derived from ascomycin by activation of the 32-hydroxy group with a triflate ester, and nucleophilic substitution with chloride under phase transfer conditions to provide the chloro analogue. Pimecrolimus has been targeted for treatment of inflammatory skin disorders. Like all tacrolimus analogues, pimecrolimus binds to receptor protein, FKBP12. The complex then binds to mTOR preventing it from interacting with target proteins. Pimecrolimus is extensively cited in the literature with over 2,000 citations.
 

Details:

high purity API Pimecrolimus 137071-32-0 exporter

1.9 years exporting experience; Mixed container, we can mix different items in one container.
2.Competitive price and quality;
3. free sample for test. after shipment,  keep sample for 2 years 
4.We are sincerely responsible for the"sample quality" , "product quality" and "After Service"; Quality control, before shipment, 
5. Prompt delivery, Prompt shipment with professional documents; 
6.Packed well; Packing as your request, with photo before shipment
7.“High-quality products, cost-effective prices, best reputation and professional services” is the managing motto of our company. 
8.We are insisting and striving ……
Just for our promise: 
“EnBridge will do our best to be better”

Enbridge PharmTech Co., Ltd. is an innovative company integrated with R&D, manufacturing, marketing and distribution of intermediates and fine chemicals, mainly used to pharmaceutical, pesticide, cosmetics, health care products and electronic chemicals. Our core services also include Custom Synthesis and Contract Manufacturing Services.
Enbridge PharmTech has one R&D center and two manufacturing bases. R&D center is equipped with good organic synthesis and analytical instrumenets. In our two production bases, we have large-scale reactors which cover various SS/ Glass Lined reactors capable of conducting high pressure, high temperature and low temperature reactions. We have a large number of well-equiped instruments and have the production capability from kilogram to ton...
 

“High-quality products, cost-effective prices, best reputation and professional services” is the managing motto of our company. We sincerely hope to establish stable, strategic and long-term business relationship with customers home and abroad to pursue more brighter future together.

 

Thanks to all the customers’ support to EnBridge Pharm and we are looking forward to making mutual benefit with all of our cooperators. Warmly welcome to visit us.

Pimecrolimus is a topical immunomodulator. It is a semi-synthetic product of ascomycin produced by Streptomyces. It is more lipophilic than tacrolimus, has a stronger affinity with the skin, and can effectively and safely control facial fat 
The symptoms and signs of dermatitis can quickly alleviate the itching symptoms of patients with dermatitis and eczema, reduce the area of ??skin lesions, and clear the signs of atopic dermatitis (eczema). It is an effective treatment for early relief and long-term control of atopic dermatitis (eczema). 
Seborrheic dermatitis is an inflammatory immune response of the body to lipophilic Malassezia. Both humoral and cellular immunity are involved in the pathogenesis. Pimecrolimus can inhibit the calcium-dependent nerves required to activate T cells. 
Transcribe proteins to selectively inhibit the activation of T cells, prevent the release of cytokines and pro-inflammatory mediators, and exhibit strong anti-inflammatory activity. 
Therefore, it is speculated that the mechanism of pimecrolimus in the treatment of seborrheic dermatitis is anti-inflammatory and immune regulation. There is no report that can directly participate in the antifungal effect, but in recent years, there have been reports in Chemicalbook that tacrolimus (a kind of 
Immunomodulators with similar chemical structure and mechanism of action) have activity against certain Malassezia species. 
Similar to tacrolimus, pimecrolimus is a cell-selective inhibitor of proinflammatory cytokine production and release. It can bind to macrophilin12 (FKBP-12) to inhibit calcium-dependent calcineurin. 
Blocking early cytokine transcription of T cells and inhibiting T cell activation, especially at the nanogram level can inhibit the synthesis of IL-2 and IFN-γ (Th1 cells) of T cells, and inhibit IL-4 and IL- 
10 (Th2 cell source) synthesis. 
In addition, in in vitro experiments, pimecrolimus can also inhibit the release of inflammatory cytokines and inflammatory mediators from antigen or IgE-stimulated mast cells [4,5]. 
Clinical data show that the blood drug concentration after topical application is very low, generally below the detected value (<0.5ng/mL). 
No accumulation of drugs.

 

 

Related Searches

Confirm to collect the product to my collection?

OKCancel

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View